Abstract:1. Alterations of potential target gene expression in the database. 2. Genetic modification and/or external Osteopontin (OPN) proteins in cells and animals demonstrated the role of OPN and the mechanisms of Akt and extracellular‐signal‐regulated kinase signalling. 3. Spatial distribution of OPN‐enriched lung epithelia and telocytes indicated their interaction. 4. Regulatory roles of OPN in cell‐cell interactions were further demonstrated by the cell co‐culture system. Background Lung epithelial cells play important roles in lung inflammation and injury, although mechanisms remain unclear. Osteopontin (OPN) has essential roles in epithelial damage and repair and in lung cancer biological behaviours. Telocyte (TC) is a type of interstitial cell that interacts with epithelial cells to alleviate acute inflammation and lung injury. The present studies aim at exploring potential mechanisms by which OPN regulates the epithelial origin lung inflammation and the interaction of epithelial cells with TCs in acute and chronic lung injury. Methods The lung disease specificity of OPN and epithelial inflammation were defined by bioinformatics. We evaluated the regulatory roles of OPN in OPN‐knockdown or over‐expressed bronchial epithelia (HBEs) challenged with cigarette smoke extracts (CSE) or in animals with genome OPN knockout (gKO) or lung conditional OPN knockout (cKO). Acute lung injury and chronic obstructive pulmonary disease (COPD) were induced by smoking or lipopolysaccharide (LPS). Effects of OPN on PI3K subunits and ERK were assessed using the inhibitors. Spatialization and distribution of OPN, OPN‐positive epithelial subtypes, and TCs were defined by spatial transcriptomics. The interaction between HBEs and TCs was assayed by the co‐culture system. Results Levels of OPN expression increased in smokers, smokers with COPD, and smokers with COPD and lung cancer, as compared with healthy nonsmokers. LPS and/or CSE induced over‐production of cytokines from HBEs, dependent upon the dysfunction of OPN. The severity of lung inflammation and injury was significantly lower in OPN‐gKO or OPN‐cKO mice. HBEs transferred with OPN enhanced the expression of phosphoinositide 3‐kinase (PI3K)CA/p110α, PIK3CB/p110β, PIK3CD/p110δ, PIK3CG/p110γ, PIK3R1, PIK3R2 or PIK3R3. Spatial locations of OPN and OPN‐positive epithelial subtypes showed the tight contact of airway epithelia and TCs. Epithelial OPN regulated the epithelial communication with TCs, and the down‐regulation of OPN induced more alterations in transcriptomic profiles than the up‐regulation. Conclusion Our data evidenced that OPN regulated lung epithelial inflammation, injury, and cell communication between epithelium and TCs in acute and chronic lung injury. The conditional control of lung epithelial OPN may be an alternative for preventing and treating epithelial‐origin lung inflammation and injury.

The Critical Role of Osteopontin (OPN) in Fibrotic Diseases

Osteopontin in Bone Metabolism and Bone Diseases

The Role of Osteopontin in Respiratory Health and Disease

Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis

Osteopontin Takes Center Stage in Chronic Liver Disease

Potential Involvement of Osteopontin in Inflammatory and Fibrotic Processes in Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension

Immunoregulatory Roles of Osteopontin in Diseases

The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages

Osteopontin, a bridge links osteoarthritis and osteoporosis

Thrombin Cleavage of Osteopontin Controls Activation of Hepatic Stellate Cells and is Essential for Liver Fibrogenesis

Epigenetic Modifications in Fibrotic Diseases: Implications for Pathogenesis and Pharmacological Targets

Role of osteopontin in oral epithelial dysplasia, oral submucous fibrosis and oral squamous cell carcinoma

Regulatory roles of Osteopontin in lung epithelial inflammation and epithelial‐telocyte interaction

Osteopontin Affects the Persistence of Beta-Glucan-induced Hepatic Granuloma Formation and Tissue Injury Through Two Distinct Mechanisms.

Pathophysiological Role of Osteopontin and Angiotensin II in Atherosclerosis.

The role of osteopontin in kidney diseases

Epigenetic modifications in fibrotic diseases: implications for pathogenesis and pharmacological targets.

Role of osteopontin in lung cancer evolution and heterogeneity.

The role of osteopontin in the progression of solid organ tumour

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities

Osteopontin Exacerbates Pulmonary Damage in Influenza-Induced Lung Injury.